IncFact
Company Profiles: Revenue, Growth, Competition

ELI LILLY Revenue, Growth & Competitor Profile

DBA LILLY ELI & CO
Last updated:

Company Awards

 
Public Company
public company
Fast Growing
Fastest Growing
Big Fish
Big Fish
Brain Power (IP)
Patent/Trademark IP
 

Company Profile & Annual Report for Eli Lilly

Access the complete profile.

Eli Lilly Fast Facts

RevenueOver $500 million    See Exact Annual Revenue
EmployeesOver 1,000Exact Company Size
Primary Industry325411 Medicinal & Botanical Manufacturing
Additional NAICS Codes32541
325412 Pharmaceutical Preparation Manufacturing
AddressLilly Corporate Ctr
Indianapolis, IN 46285

lilly.com


Eli Lilly's annual revenues are over $500 million (see exact revenue data) and has over 1,000 employees. It is classified as operating in the Medicinal & Botanical Manufacturing industry.


Eli Lilly's Annual Report & Profile shows critical firmographic facts:
  • What is the company's size? (Annual sales and employees)
  • What industry is the company in?

Eli Lilly is a publicly traded company on NYQ using the ticker symbol LLY. Detailed information on company financials and operating reports can be found here: NYQ: LLY



Eli Lilly Annual Revenue and Growth Rate

Eli Lilly Revenue Est.
($ Million)
Growth Rate (%)# Employees
2023 Details in Premium Report
2022
2021
2020
2019


1-Year Growth Rate:
3-Year Growth Rate (CAGR):
Premium Report

Note: Eli Lilly's revenues are gauged from an analysis of company filings.



Trademark Applications

Trademark applications show the products and services that Eli Lilly is developing and marketing. Eli Lilly's new tradmarks suggest it is investing in R&D and marketing, while expanding into new products or markets. Trademarks may include brand names, product names, logos and slogans.

Trademark Date
TWILGECY
Pharmaceutical preparations, namely, pharmaceutical preparations for the treatment of alopecia, Alzheimer's disease, atopic dermatitis, autoimmune diseases and disorders, blood diseases and disorders, bone and skeletal diseases and disorders, cancer, cardiovascular diseases, central nervous system diseases and disorders, cluster headaches, Coronavirus disease, Crohn's disease, dementia, dermatological diseases and disorders, diabetes, dyslipidemia, endocrine diseases and disorders, fibromyalgia, gastrointestinal diseases and disorders, headaches, hearing loss, heart failure, inflammation and inflammatory diseases and disorders, inflammatory bowel disease, kidney diseases and disorders, liver diseases and disorders, lupus, mental disorders, metabolic diseases and disorders, migraines, multiple sclerosis, neurodegenerative diseases and disorders, neurological disorders, obesity, osteoarthritis, pain, Parkinson's disease, Psoriasis, Psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, vascular diseases
01/25/2024
WHAT TIME HIDES
Providing medical information in the field of Alzheimer's and related diseases.
01/16/2024
CONNECTAD
Educational services, namely, programs for healthcare personnel about clinical cases and communication practices in the area of Alzheimer disease
01/16/2024

See all trademarks and details in the Full Report.


Recession Risk

Determine whether Eli Lilly grew or shrank during the last recession. This is useful in estimating the financial strength and credit risk of the company. Compare how recession-proof Eli Lilly is relative to the industry overall. While a new recession may strike a particular industry, measuring the industry and company's robustness during the last recession estimates its ability to weather future recessions.



U.S. Industry Overview & Market Statistics:
Medicinal & Botanical Manufacturing

Publisher: AnythingResearch

  • Market Size
  • Growth Rate
  • 5-Year Market Forecast
  • Average Company Size & Growth
  • Salary & Compensation Benchmarks



Market Share of Eli Lilly's Largest Competitors

A competitive analysis shows these companies are in the same general field as Eli Lilly, even though they may not compete head-to-head. These are the largest companies by revenue. However, they may not have the largest market share in this industry if they have diversified into other business lines. The "Competition" section of a business plan or investment memorandum would start by analyzing the information about these companies. Competitive advantage comes from offering better pricing or superior products/service.

Company HeadquartersRevenue ($ MM)
VITALABSMcdonough, GA100 
COUNTRY LANE SALESFairview, UT81 
VITA-PURERoselle, NJ44 
INPIVOTALindon, UT42 
NEW SPIRIT NATURALSSan Dimas, CA24 
MICROBE FORMULASMeridian, ID14 
EXEGI PHARMARockville, MD13 
MEDS & FOOD FOR KIDSSaint Louis, MO9 




Nearby Competitors

These companies are similar in business line and location to Eli Lilly. While some companies compete with neighboring businesses for customers, other companies may compete to attract skilled employees.

Company HeadquartersRevenue ($ MM)
ELI LILLYIndianapolis, IN100 
ROCHE DIAGNOSTICSIndianapolis, IN5 
EXELEADIndianapolis, IN2 
3CFishers, IN1 
POINT BIOPHARMAIndianapolis, IN0 




Future Competition: Eli Lilly's Fastest Growing Competitors

These companies are in the same general field as Eli Lilly and are rapidly expanding. Companies may grow organically or through acquisition. In some cases apparently high growth rates may be caused by data that weren't available in previous years.

CompanyRevenue ($ MM)
Eli Lilly Competitors